Latest Industry Press Releases More...

We bring you the latest pharmaceutical press releases in our pharmaceutical Industry Press Releases section to help our clients gain great exposure on industry happenings. Know about mergers, deals, technology release, and other information first hand from press conferences of industry leaders with our Global pharmaceuticals Industry Press Releases.

Press Releases

MiMedx Group, Inc., the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today that it has signed a definitive agreement with the former stockholders of Stability Inc. to divest the Company's subsidiary, Stability Biologics…

Press Releases

Teva Pharmaceutical Industries Ltd., today announced the launch of generic Axiron®1 (testosterone) topical solution CIII, 30 mg/1.5 mL, in the U.S. Testosterone topical solution CIII is a prescription medicine used to treat adult males who have low or no testosterone due to certain medical conditions. It is supplied in a…

Press Releases

We are pleased to announce the appointment of Andre Goodson as our new Global Systems Director. Andre will use his wealth of commercial leadership experience to bring fresh ideas to our sales processes, ensuring we are customer focussed and will also be responsible for overseeing the development of our Systems…

Press Releases

WuXi Biologics, a global leading open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and its Chinese partner Harbin Gloria Pharmaceuticals Co Ltd (002437.CN), today announced that an exclusive license to the anti-PD-1 antibody GLS-010 has been granted to Arcus Biosciences, a US-based biotechnology company…

Press Releases

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced initiation of the Cytisine Clinical Development Program. Cytisine is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe for more than…

Press Releases

Medpace Holdings, Inc. today announced it has entered into a stock repurchase agreement (the “Stock Repurchase Agreement”) with investment funds affiliated with Cinven Capital Management (V) General Partner Limited (“Cinven”). Under the terms of the Stock Repurchase Agreement with Cinven, Medpace has agreed to repurchase 2,000,000 shares of Medpace’s common…

Press Releases

Today Lonza announced an endothelial cell application center, which expands Lonza’s support for researchers. This new online suite provides scientists with educational materials and product information to assist with vital endothelial cell research. As endothelial cells regulate many homeostatic processes within the body, their dysfunction has important implications for diseases,…

Press Releases

Takeda Pharmaceutical Company Limited announced a collaboration with Stanford University to form the Stanford Alliance for Innovative Medicines (Stanford AIM), which will help transform novel Stanford research into next-generation treatments for diseases. Through this unique collaboration, Takeda and Stanford will identify projects on the path to therapeutic discoveries and accelerate…

Press Releases

On August 9, 2017, the U.S. Patent & Trademark Office (PTO) granted Argentum Pharmaceuticals LLC's petition for inter partes review (IPR) against all claims of the last-expiring patent listed in the Food & Drug Administration's Orange Book covering Novartis AG's GILENYA® (fingolimod) drug. Argentum Pharmaceuticals challenges claims 1−6 of Novartis'…

Press Releases

Mylan Pharmaceuticals ULC, a subsidiary of Mylan N.V., a leading global pharmaceutical company, today announced the launch in Canada of three generic products indicated in the treatment of HIV for certain patients. One of the products is Mylan-Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg, a generic alternative to Truvada®. Mylan received…

loader